Articles by Matthew Zibelman, MD
The panel discusses studies and areas of interest related to treatment options for advanced bladder cancer.
The panel discussed how treatments used in the metastatic space are moving into the perioperative setting.
The panel discusses the potential for more targeted treatments making their way into the advanced bladder cancer space.
The panel addresses treatment sequencing decisions following disease relapse.
The panel discusses the approach to treating patients with platinum-ineligible bladder cancer.
The panel discusses patient characteristics and treatment sequencing considerations.
The panel discusses the approach to treating patients with cisplatin-ineligible bladder cancer.
The panel discusses the approach to treating patients with cisplatin-eligible bladder cancer.
Matthew Zibelman, MD, highlights SOC adjuvant therapy for localized RCC and practice-changing potential of novel therapies.
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.